This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Jan;226(1):152-153.

doi: 10.1016/j.ajog.2021.08.043. Epub 2021 Sep 2.

INTERCOVID prospective longitudinal study: preeclampsia and COVID-19

David Desseauve¹, Leo Pomar², David Baud²

Affiliations

Affiliations

¹ Obstetric Research Lab, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Electronic address: david.desseauve@chuv.ch.
² Materno-Fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

PMID: 34481771
PMCID: PMC8411594
DOI: 10.1016/j.ajog.2021.08.043

INTERCOVID prospective longitudinal study: preeclampsia and COVID-19

David Desseauve et al. Am J Obstet Gynecol. 2022 Jan.

. 2022 Jan;226(1):152-153.

doi: 10.1016/j.ajog.2021.08.043. Epub 2021 Sep 2.

Authors

David Desseauve¹, Leo Pomar², David Baud²

Affiliations

¹ Obstetric Research Lab, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Electronic address: david.desseauve@chuv.ch.
² Materno-Fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

PMID: 34481771
PMCID: PMC8411594
DOI: 10.1016/j.ajog.2021.08.043

No abstract available

PubMed Disclaimer

Comment in

Preeclampsiada risk factor to get infected with COVID-19 or a selection bias?
Boujenah J. Boujenah J. Am J Obstet Gynecol. 2022 Jan;226(1):152. doi: 10.1016/j.ajog.2021.08.042. Epub 2021 Sep 2. Am J Obstet Gynecol. 2022. PMID: 34481776 Free PMC article. No abstract available.

References

1. Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653–1659. - PMC - PubMed
1. Papageorghiou A.T., Deruelle P., Gunier R.B., et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021;225:289.e1–289.e17. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information